Subject: DOXIL J9001 – EFFECTIVE 7/1/12
The Centers for Medicare & Medicaid Services’ (CMS) HCPCS Quarterly update includes 2 new codes (Q2048 and Q2049) for liposomal doxorubicin that will become effective July 1, 2012. The code descriptors are worded in a manner that distinguishes Lipodox and Doxil. As of July 1, 2012, HCPCS code J9001 will not be used for Medicare billing.
Q2048 – Doxil Injection 10MG
Q2409 – Imported Lipodox 10MG